Increased alpha-taxilin protein expression is associated with the metastatic and invasive potential of renal cell cancer

Biomedical Research

Volumn 32, Issue 2, 2011, Pages 103-110

  Mashidori, Tomoko ^a   Shirataki, Hiromichi ^a   Kamai, Takao ^a   Nakamura, Fumihiko ^a   Yoshida, Ken Ichiro ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TAXILIN; ONCOPROTEIN; SYNTAXIN 4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CELL MIGRATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; METASTASIS POTENTIAL; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIMARY TUMOR; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE LEVEL; WESTERN BLOTTING;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; QA-SNARE PROTEINS; TUMOR MARKERS, BIOLOGICAL; VESICULAR TRANSPORT PROTEINS;

EUKARYOTA;

EID: 79957713187     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.32.103     Document Type: Article

References (45)

1. Athar U and Gentile TC (2008) Treatment options for meta-static renal cell carcinoma: a review. Can J Urol 15, 523-532.
2. Bascom JL, Fata JE, Hirai Y, Sternlicht MD and Bissell MJ (2005) Epimorphin overexpression in the mouse mammary gland promotes alveolar hyperplasia and mammary adenocar-cinoma. Cancer Res 65, 8617-8621.
3. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z and Hanahan D (2000) Matrix metalloproteinase-9 trigers the angiogenic switch during carcinogenesis. Nat Cell Biol 2, 737-744.
4. Braat AK, Yan N, Arn E, Harrison D and Macdonald PM (2004) Localization-dependent Oskar protein accumulation; control after the initiation of translation. Dev Cell 7, 125-131.
5. Coppin C (2008) Immunotherapy for renal cell cancer in the era of targeted therapy. Expert Rev Anticancer Ther 8, 97-103.
6. Etienne-Manneville S and Hall A (2002) Rho GTPases in cell biology. Nature 420, 629-635.
7. Fritz G, Just I and Kaina B (1999) Rho GTPase over-expressed in human tumors. Int J Cancer 81, 682-687.
8. Fuhrman SA, Lasky LC, Lmas C, Motzer RJ, Russo P, Nanus DM and Berg WJ (1982) Renal cell carcinoma. Am J Surg Pathol 6, 655-663.
9. Griedl P and Wolf K (2003) Tumour-cell invasion and migra-tion: diversity and escape mechanisms. Nat Rev Cancer 3, 362-374.
10. Jahn R, Lang T and Sudhof TC (2003) Membrane fusion. Cell 112, 519-533.
11. Jahn R and Scheller RH (2006) SNAREs-engines for mem-brane fusion. Nat Rev Mol Cell Biol 7, 631-643.
12. Jallepalli PV and Lengauer C (2001) Chromosome segrega-tion and cancer: cutting through the mystery. Nat Rev Cancer 1, 109-117.
13. Jantzer P and Schendel DJ (1998) Human renal carcinoma antigen-specific CTLs, antigen-driven selection and long-term persistence in vivo. Cancer Res 58, 3078-3086.
14. Jones MC, Caswell PT and Norman JC (2006) Endocytic re-cycling pathways: emerging regulators of cell migration. Curr Opin Cell Biol 18, 549-557.
15. Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y, Oshima H and Yoshida K-I (2003) Significant association of Rho/ROCK pathway with invasion and metastasis of bladder can-cer. Clin Cancer Res 9, 2632-2641.
16. Kamai T, Shirataki H, Nakanishi K, Furuya N, Kambara T, Abe H, Oyama T and Yoshida K-I (2010) Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer. BMC Cancer 10, 1471-2407-10-164.
17. Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N and Ross JS (2001) Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res 7, 3113-3119.
18. Kean MJ, Williams KC, Skalski M, Myers D, Burtnik A, Foster D and Coppolino MG (2009) VAMP3, syntaxin-13 and SNAP23 are involved in secretion of matrix metalloproteinases, degradation of the extracellular matrix and cell invasion. J Cell Sci 122, 4089-4098.
19. Kroes RA, Jastrow A, McLone MG, Yamamoto H, Colley P, Kersey DS, Yong VW, Mkrdichian E, Cerullo L, Leestma J and Moskal J (2000) The identification of novel therapeutic targets for the treatment of malignant brain tumors. Cancer Lett 156, 191-198.
20. Moreau A, Yotov WV, Glorieux FH and St-Arnaud R (1998) Bone-specific expression of the alpha chain of the nascent polypeptide-associated complex, a coactivator potentiating c-Jun-mediated transcription. Mol Cell Biol 18, 1312-1321.
21. Linehan WM, Walther MM and Zbar B (2003) The genetic basis of cancer of the kidney. J Urol 170, 2163-2172.
22. Miyata T, Ohnishi H, Suzuki J, Yoshikumi Y, Ohno H, Mashima H, Yasuda H, Ishijima T, Osawa H, Satoh K, Sunada K, Kita H, Yamamoto H and Sukuno K (2004) Involvement of syntaxin 4 in the transport of membrane-type 1 matrix metalloproteinase to the plasma membrane in human gastric epithelial cells. Biochem Biophys Res Commun 323, 118-124.
23. Motzer RJ, Bander NH and Nanus DM (1996) Renal-cell carcinoma. N Engl J Med 335, 865-875.
24. Nabi IR (1999) The polarization of the motile cell. J Cell Sci 112, 1803-1811.
25. Nakanishi K, Kamai T, Mizuno T, Arai K and Yamanishi T (2009) Expression of RhoA mRNA and activated RhoA in urothelium and smooth muscle, and effects of a Rho-kinase inhibitor on contraction of the porcine urinary bladder. Neurourol Urodynam 28, 521-528.
26. 2+-dependent exocytosis in neuroendocrine cells. Genes Cells 8, 17-28.
27. Nogami S, Satoh S, Nakano M, Terano A and Shirataki H (2003) Interaction of taxilin with syntaxin which does not form the SNARE complex. Biochem Biophys Res Commun 311, 797-802.
28. Nogami S, Satoh S, Tanaka-Nakadate S, Yoshida K, Nakano M, Terano A and Shirataki H (2004) Identification and characterization of taxilin isoforms. Biochem Biophys Res Commun 319, 936-943.
29. Oba-Shinjo SM, Benqtson MH, Winnisvhofer SM, Colin C, Vedoy CG, de Mendonca A, Marie SK and Soqayar MC (2005) Identification of novel differentially expressed genes in human astrocytomas by cDNA representational difference analysis. Brain Res Mol Brain Res 140, 25-33.
30. Oya M, Mikami S, Mizuno R, Marumo K, Mukai M and Murai M (2005) C-jun activation in acquired cyctic kidney disease and renal cell carcinoma. J Urol 174, 726-730.
31. Papachristou DJ, Batistatou A, Sykiotis GP, Varakis I and Papavassiliou AG (2003) Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone 32, 364-371.
32. Quigley JP and Armstrong PB (1998) Tumor cell intravasa-tion alu-cidated; The chick embryo opens the window. Cell 94, 281-284.
33. Quelo I, Akhouayri O, Prudhomme J and St-Arnaud R (2004) GSK3b-dependent phosphorylation of the αNAC coactivator regulates its nuclear translocation and proteasome-mediated degradation. Biochemistry 43, 2906-2914.
34. Quelo I, Gauthier C, Hannigan GE, Dedhar S and St-Arnaud R (2004) Integrin-linked kinase regulates the nuclear entry of the c-Jun coactivator α-NAC and its coactivation potency. J Biol Chem 279, 43893-43899.
35. Rospert S, Dubaquie Y and Gautschi M (2002) Nascent-poly-peptide-associated complex. Cell Mol Life Sci 59, 1632-1639.
36. Sahai E and Marshall CJ (2002) Rho-GTPases and cancer. Nat Rev Cancer 2, 133-142.
37. Sakakibara S, Nakadate K, Tanaka-Nakadate S, Yoshida K, Nogami S, Shirataki H and Ueda S (2008) Developmental and spatial expression pattern of alpha-taxilin in the rat central nervous system. J Comp Neurol 511, 65-80.
38. Sciarra A, Gentile V, Salciccia S, Alfarone A and Di Silverio F (2008) New anti-angiogenic targeted therapy in advanced renal cell carcinoma (RCC): current status and future prospects. Rev Recent Clin Trials 3, 97-103.
39. Sobin H and Wittekind CH, eds. (2002) International union against cancer. UICC, In TNM Classification of Malignant Tumors, 6rd ed. Wiley-Liss, New York.
40. Stetler-Stevenson WG, Liotta LA and Kleiner DE Jr (1993) Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7, 1434-1441.
41. Suwa H, Ohshio G, Imamura T, Watanabe G, Arii S, Imamura M, Narumiya S, Hiai H and Fukumoto M (1998) Overex-pression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer 77, 147-152.
42. Tayeb MA, Skalski M, Cha MC, Kean MJ, Scaife M and Coppolino MG (2005) Inhibition of SNARE-mediated membrane traffic impairs cell migration. Exp Cell Res 305, 63-73.
43. Wright PK (2008) Targeting vesicle trafficking: An important approach to cancer chemotherapy. Recent Pat Anticancer Drug Discov 3, 137-147.
44. Yoshida K, Nogami S, Satoh S, Tanaka-Nakadate S, Hiraishi H, Terano A and Shirataki H (2005) Interaction of the taxilin family with the nascent polypeptide-associated complex that is involved in the transcriptional and translational processes. Genes Cells 10, 465-476.
45. Yu VW, Gauthier C and St-Arnaud R (2006) Inhibition of ATF4 transcriptional activity by FIAT/gamma-taxilin modulates bone mass accrual. Ann N Y Acad Sci 1068, 131-142.